Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide

Overview of attention for article published in JNCI: Journal of the National Cancer Institute, December 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source

twitter: 9 X users
guideline: 3 clinical guideline sources

Readers on

mendeley: 166 Mendeley
citeulike: 3 CiteULike

So far, Altmetric has seen 11 X posts from 9 X users, with an upper bound of 14,364 followers.

@PavelEGT @raulossio @UNAM_MX Publicó este artículo: https://t.co/vSBDVXmUMK Y este otro de aplicación de la herramienta: https://t.co/6bfWKg0eCa Este comment: https://t.co/8vDPgiWdxu Y esperamos poner otro en biorxiv antes de que termine el año 😊

RT @haverdal76: Our latest paper, "Comprehensive Study of the Clinical Phenotype of Germline #BAP1 Variant-Carrying Families Worldwide." fr…

Lifetime risk for any cancer in the #BAP1 cancer syndrome is > 80%. Most common tumors are #uvealmelanoma and #mesotheilioma #jnci https://t.co/zaKCNP6ttJ https://t.co/Ow50nxeAbl

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 7 additional X posts.